Induced Pluripotency for Translational Research

Genomics, Proteomics and Bioinformatics

Volumn 11, Issue 5, 2013, Pages 288-293

  Wu, Menghua ^a   Chen, Guilai ^a   Hu, Baoyang ^a  

^a INSTITUTE OF ZOOLOGY   (China)

Author keywords

Cell fate decision; IPSCs; Pluripotency; Translational medicine

Indexed keywords

CELL FATE; CELL LINEAGE; EMBRYONIC STEM CELL; HUMAN; NONHUMAN; PERSONALIZED MEDICINE; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; REVIEW; TRANSLATIONAL RESEARCH;

CELL FATE DECISION; IPSCS; PLURIPOTENCY; TRANSLATIONAL MEDICINE;

ANIMALS; CELL LINEAGE; CELL NUCLEUS; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NUCLEAR TRANSFER TECHNIQUES; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84886445085     PISSN: 16720229     EISSN: 22103244     Source Type: Journal    
DOI: 10.1016/j.gpb.2013.08.001     Document Type: Review

References (46)

1. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
2. Briggs R., King T.J. Transplantation of living nuclei from blastula cells into enucleated frogs' eggs. Proc Natl Acad Sci U S A 1952, 38:455-463.
3. King T.J., Briggs R. Changes in the nuclei of differentiating gastrula cells, as demonstrated by nuclear transplantation. Proc Natl Acad Sci U S A 1955, 41:321.
4. Gurdon J., Laskey R., Reeves O. The developmental capacity of nuclei transplanted from keratinized skin cells of adult frogs. J Embryol Exp Morphol 1975, 34:93.
5. Gurdon J.B. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol 1962, 10:622-640.
6. Wilmut I., Schnieke A.E., McWhir J., Kind A.J., Campbell K.H. Viable offspring derived from fetal and adult mammalian cells. Nature 1997, 385:810-813.
7. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
8. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981, 78:7634-7638.
9. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
10. Smith A.G., Heath J.K. Inhibition of pluripotential embryonic stem cell differentiation by. Nature 1988, 336:639.
11. Davis R.L., Weintraub H., Lassar A.B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987, 51:987-1000.
12. Schneuwly S., Klemenz R., Gehring W.J. Redesigning the body plan of Drosophila by ectopic expression of the homoeotic gene Antennapedia. Nature 1987, 325:816-818.
13. Laiosa C.V., Stadtfeld M., Xie H., de Andres-Aguayo L., Graf T. Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBPá and PU. 1 transcription factors. Immunity 2006, 25:731-744.
14. Xie H., Ye M., Feng R., Graf T. Stepwise reprogramming of B cells into macrophages. Cell 2004, 117:663-676.
15. Maherali N., Sridharan R., Xie W., Utikal J., Eminli S., Arnold K., et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007, 1:55-70.
16. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
17. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448:318-324.
18. Zhao X.Y., Li W., Lv Z., Liu L., Tong M., Hai T., et al. IPS cells produce viable mice through tetraploid complementation. Nature 2009, 461:86-90.
19. Lowry W., Richter L., Yachechko R., Pyle A., Tchieu J., Sridharan R., et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 2008, 105:2883-2888.
20. Park I.-H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2007, 451:141-146.
21. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
22. Esteban M.A., Wang T., Qin B., Yang J., Qin D., Cai J., et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 2010, 6:71-79.
23. Li R., Liang J., Ni S., Zhou T., Qing X., Li H., et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010, 7:51-63.
24. Liu X., Sun H., Qi J., Wang L., He S., Liu J., et al. Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming. Nat Cell Biol 2013, 15:829-838.
25. Samavarchi-Tehrani P., Golipour A., David L., Sung H.K., Beyer T.A., Datti A., et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010, 7:64-77.
26. Waddington C.H. The strategy of the genes: a discussion of some aspects of theoretical biology 1957, Allen & Unwin, London. 1st ed.
27. Shu J., Wu C., Wu Y., Li Z., Shao S., Zhao W., et al. Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell 2013, 153:963-975.
28. Ladewig J., Koch P., Brustle O. Leveling Waddington: the emergence of direct programming and the loss of cell fate hierarchies. Nat Rev Mol Cell Bio 2013, 14:225-236.
29. Hou P., Li Y., Zhang X., Liu C., Guan J., Li H., et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 2013, 341:651-654.
30. Hu B.Y., Zhang S.C. Differentiation of spinal motor neurons from pluripotent human stem cells. Nat Protoc 2009, 4:1295-1304.
31. Swistowski A., Peng J., Liu Q., Mali P., Rao M.S., Cheng L., et al. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem cells 2010, 28:1893-1904.
32. Zeng H., Guo M., Martins-Taylor K., Wang X., Zhang Z., Park J.W., et al. Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells. PloS One 2010, 5:e11853.
33. Marchetto M.C., Carromeu C., Acab A., Yu D., Yeo G.W., Mu Y., et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010, 143:527-539.
34. Devine M.J., Ryten M., Vodicka P., Thomson A.J., Burdon T., Houlden H., et al. Parkinson's disease induced pluripotent stem cells with triplication of the á-synuclein locus. Nat Commun 2011, 2:440.
35. Israel M.A., Yuan S.H., Bardy C., Reyna S.M., Mu Y., Herrera C., et al. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 2012, 482:216-220.
36. Yagi T., Ito D., Okada Y., Akamatsu W., Nihei Y., Yoshizaki T., et al. Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum Mol Genet 2011, 20:4530-4539.
37. Yahata N., Asai M., Kitaoka S., Takahashi K., Asaka I., Hioki H., et al. Anti-Abeta drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease. PloS One 2011, 6:e25788.
38. Chae J.I., Kim D.W., Lee N., Jeon Y.J., Jeon I., Kwon J., et al. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient. Biochem J 2012, 446:359-371.
39. Brennand K.J., Simone A., Jou J., Gelboin-Burkhart C., Tran N., Sangar S., et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011, 473:221-225.
40. Kondo T., Asai M., Tsukita K., Kutoku Y., Ohsawa Y., Sunada Y., et al. Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aâ and differential drug responsiveness. Cell Stem Cell 2013, 12:487-496.
41. Kim J., Hoffman J.P., Alpaugh R.K., Rhimm A.D., Reichert M., Stanger B.Z., et al. An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression. Cell Rep 2013, 3:2088-2099.
42. Peng J., Liu Q., Rao M.S., Zeng X. Using human pluripotent stem cell-derived dopaminergic neurons to evaluate candidate Parkinson's disease therapeutic agents in MPP+ and rotenone models. J Biomol Screen 2013, 18:522-533.
43. Lee G., Ramirez C.N., Kim H., Zeltner N., Liu B., Radu C., et al. Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression. Nat Biotechnol 2012, 30:1244-1248.
44. Yang Y., Gupta S., Kim K., Powers B., Cerqueira A., Wainger B., et al. A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell 2013, 12:713-726.
45. Hanna J., Wernig M., Markoulaki S., Sun C.W., Meissner A., Cassady J.P., et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007, 318:1920-1923.
46. Wang S., Bates J., Li X., Schanz S., Chandler-Militello D., Levine C., et al. Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 2013, 12:252-264.